✦ LIBER ✦

The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update

✍ Scribed by J. M. Lusher; D. A. Roth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and inhibitor development in pr

✍ Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Continuous infusion of B-domain deleted

✍ N. Stieltjes; C. Altisent; G. Auerswald; C. Négrier; P. Pouzol; J. Reynaud; V. R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Efficacy and inhibitor development in pr

✍ Peter Larson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Stability, efficacy, and safety of conti

✍ U. MARTINOWITZ; J. LUBOSHITZ; D. BASHARI; B. RAVID; E. GORINA; L. REGAN; H. STAS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Clinical efficacy, safety and pharmacoki

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

An open clinical study assessing the eff

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. MONTAÑES; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB